Evaluation category | Arm | Number of clusters | Number of patients | Prevalence number (%) | Crude RD a (95% CI) | Adjusted RD b (95% CI) | P -value |
---|---|---|---|---|---|---|---|
Overallc(all ages) | Control | 12 | 8942 | 749 (8%) | 0 | 0 | Â |
HW | 12 | 10118 | 250 (2%) | 0.06 (0.04, 0.09) | 0.04 (0.01, 0.06) | 0.008 | |
HWP | 12 | 10163 | 184 (2%) | 0.07 (0.04, 0.09) | 0.04 (0.01, 0.06) | 0.005 | |
<5Â years | Control | 12 | 3139 | 392 (12%) | 0 | 0 | Â |
HW | 12 | 3682 | 153 (4%) | 0.09 (0.04, 0.14) | 0.06 (0.006, 0.12) | 0.03 | |
HWP | 12 | 3406 | 95 (3%) | 0.09 (0.03, 0.14) | 0.05 (0.005, 0.09) | 0.03 | |
≥5 years | Control | 12 | 5803 | 357 (6%) | 0 | 0 |  |
HW | 12 | 6436 | 97 (2%) | 0.05 (0.03, 0.07) | 0.02 (0.006, 0.04) | 0.008 | |
HWP | 12 | 6757 | 89 (1%) | 0.05 (0.03, 0.07) | 0.03 (0.01, 0.05) | 0.002 | |
By Evaluation period | |||||||
Standard training - period 1 (all arms) | Control | 12 | 656 | 48 (7%) | 0 | 0 | Â |
HW | 9 | 449 | 3 (1%) | - | - | - | |
HWP | 11 | 494 | 38 (8%) | 0.001 (−0.09, 0.09) | −0.01 (−0.06, 0.03) | 0.54 | |
Interactive training - period 2 (HW and HWP arms) | Control | 12 | 3320 | 236 (7%) | 0 | 0 | Â |
HW | 12 | 3791 | 135 (4%) | 0.05 (0.02, 0.08) | 0.02 (−0.001, 0.05) | 0.06 | |
HWP | 12 | 3802 | 81 (2%) | 0.05 (0.02, 0.09) | 0.03 (0.003, 0.05) | 0.03 | |
Feedback SMS – period 3 (HW and HWP arms) | Control | 12 | 2392 | 215 (9%) | 0 | 0 |  |
HW | 12 | 2829 | 58 (2%) | 0.06 (0.04, 0.09) | 0.02 (−0.001, 0.05) | 0.06 | |
HWP | 12 | 2891 | 24 (1%) | 0.07 (0.04, 0.10) | 0.02 (−0.004, 0.04) | 0.09 | |
Feedback + proverb SMS - period 4 (HW and HWP arms) | Control | 12 | 1297 | 106 (8%) | 0 | 0 |  |
HW | 12 | 1540 | 18 (1%) | 0.07 (0.05, 0.09) | 0.03 (0.007, 0.06) | 0.01 | |
HWP | 12 | 1607 | 7 (0.4%) | 0.07 (0.05, 0.09) | 0.03 (0.01, 0.06) | 0.009 |